Information Provided By: 
Fly News Breaks for July 25, 2017
PKI
Jul 25, 2017 | 11:02 EDT
Piper Jaffray analyst William Quirk raised his price target for PerkinElmer shares to $80 to reflect the acquisition of Euroimmun. The potential for re-accelerating top and bottom-line growth should keep shares "inching higher," Quirk tells investors in a research note. He recommends using any weakness related to declining U.S. birth rates, which he notes could weigh on the company's domestic newborn screening business in the short to mid-term, as a buying opportunity. The analyst keeps an Overweight rating on PerkinElmer.
News For PKI From the Last 2 Days
There are no results for your query PKI
